Red2Onco, an innovative genetic mouse model, allows to detect the very initial steps that lead to cancer development. Red2Onco’s multicolor labeling system allows to trace intestinal tumor development after the first oncogenic hit at the single cell level. The research carried out at IMBA—Institute of Molecular Biotechnology of the Austrian Academy of Sciences—and the University of Cambridge is now published in the journal Nature.